Literature DB >> 16633713

Proteomic analysis of prodigiosin-induced apoptosis in a breast cancer mitoxantrone-resistant (MCF-7 MR) cell line.

Marta Monge1, Marta Vilaseca, Vanessa Soto-Cerrato, Beatriz Montaner, Ernest Giralt, Ricardo Pérez-Tomás.   

Abstract

Prodigiosin (PG) is a bacterial, red-pigmented antibiotic with immunosuppressive and apoptotic activities. To better understand its mechanisms of action, we tried to identify proteins associated with apoptosis induced by PG. For this purpose, the variation of protein expression on exposure to apoptotic concentrations of PG was examined, by high-resolution two-dimensional gel electrophoresis (2D-E), in the MCF-7 cancer cell line resistant to mitoxantrone (MCF-7-MR). Six PG apoptosis-associated protein spots were further characterized by complementary peptide mass fingerprinting and tandem mass spectrometry data obtained on a matrix-assisted laser desorption ionization-time-of-flight/time-of-flight (MALDI-TOF/TOF) mass spectrometer. The proteins identified were involved in various cellular functions, including cell defence, DNA repair and cellular organization. Our data provide novel information on cell response to PG, a new apoptotic drug with interesting anticancer activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16633713     DOI: 10.1007/s10637-006-7774-8

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  36 in total

Review 1.  Proteomics in biomarker discovery and drug development.

Authors:  Qing-Yu He; Jen-Fu Chiu
Journal:  J Cell Biochem       Date:  2003-08-01       Impact factor: 4.429

2.  Effects of the proapoptotic drug prodigiosin on cell cycle-related proteins in Jurkat T cells.

Authors:  R Pérez-Tomás; B Montaner
Journal:  Histol Histopathol       Date:  2003-04       Impact factor: 2.303

3.  Prodigiosins as a new group of H+/Cl- symporters that uncouple proton translocators.

Authors:  T Sato; H Konno; Y Tanaka; T Kataoka; K Nagai; H H Wasserman; S Ohkuma
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

4.  The versatility of cytokeratins as tumor markers.

Authors:  T Stigbrand
Journal:  Tumour Biol       Date:  2001 Jan-Feb

5.  Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

Authors:  D D Ross; W Yang; L V Abruzzo; W S Dalton; E Schneider; H Lage; M Dietel; L Greenberger; S P Cole; L A Doyle
Journal:  J Natl Cancer Inst       Date:  1999-03-03       Impact factor: 13.506

6.  Prodigiosin induces cell death and morphological changes indicative of apoptosis in gastric cancer cell line HGT-1.

Authors:  C Díaz-Ruiz; B Montaner; R Pérez-Tomás
Journal:  Histol Histopathol       Date:  2001-04       Impact factor: 2.303

7.  Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines.

Authors:  B Montaner; S Navarro; M Piqué; M Vilaseca; M Martinell; E Giralt; J Gil; R Pérez-Tomás
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

8.  The cytotoxic prodigiosin induces phosphorylation of p38-MAPK but not of SAPK/JNK.

Authors:  Beatriz Montaner; Ricardo Pérez-Tomás
Journal:  Toxicol Lett       Date:  2002-03-24       Impact factor: 4.372

Review 9.  The prodigiosins: a new family of anticancer drugs.

Authors:  Beatriz Montaner; Ricardo Pérez-Tomás
Journal:  Curr Cancer Drug Targets       Date:  2003-02       Impact factor: 3.428

10.  Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.

Authors:  Gero Kramer; Hamdiye Erdal; Helena J M M Mertens; Marius Nap; Julian Mauermann; Georg Steiner; Michael Marberger; Kenneth Bivén; Maria C Shoshan; Stig Linder
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

View more
  5 in total

1.  Proteomics analysis of MPP+-induced apoptosis in SH-SY5Y cells.

Authors:  Hongrong Xie; Ming Chang; Xinyu Hu; Danping Wang; Mingxiu Tian; Guoyi Li; Huiyi Jiang; Ying Wang; Zhong Dong; Yuhua Zhang; Linsen Hu
Journal:  Neurol Sci       Date:  2010-06-19       Impact factor: 3.307

2.  Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.

Authors:  Changhua Zhou; Ashley M Nitschke; Wei Xiong; Qiang Zhang; Yan Tang; Michael Bloch; Steven Elliott; Yun Zhu; Lindsey Bazzone; David Yu; Christopher B Weldon; Rachel Schiff; John A McLachlan; Barbara S Beckman; Thomas E Wiese; Kenneth P Nephew; Bin Shan; Matthew E Burow; Guangdi Wang
Journal:  Breast Cancer Res       Date:  2008-12-16       Impact factor: 6.466

Review 3.  Production and Potential Applications of Bioconversion of Chitin and Protein-Containing Fishery Byproducts into Prodigiosin: A Review.

Authors:  San-Lang Wang; Van Bon Nguyen; Chien Thang Doan; Thi Ngoc Tran; Minh Trung Nguyen; Anh Dzung Nguyen
Journal:  Molecules       Date:  2020-06-13       Impact factor: 4.411

4.  PG-Priming Enhances Doxorubicin Influx to Trigger Necrotic and Autophagic Cell Death in Oral Squamous Cell Carcinoma.

Authors:  Shian-Ren Lin; Ching-Feng Weng
Journal:  J Clin Med       Date:  2018-10-21       Impact factor: 4.241

5.  Prodigiosin-Emerged PI3K/Beclin-1-Independent Pathway Elicits Autophagic Cell Death in Doxorubicin-Sensitive and -Resistant Lung Cancer.

Authors:  Wei-Jun Chiu; Shian-Ren Lin; Yu-Hsin Chen; May-Jwan Tsai; Max K Leong; Ching-Feng Weng
Journal:  J Clin Med       Date:  2018-10-03       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.